HUMANA INC (HUM) Earnings History

4 quarters held2/8 transcripts analyzed2/20 figures attested
Connect your agent
PeriodRevenueYoYNet incomeEPS (dil.)Filed
Q2 2026$40.9B+26.2%$693.0M$5.73Jul 29, 2026
LATESTEarnings filing (8-K)10-QFiled Jul 29, 2026, 6:19 AM ET
Earnings call · Jul 29, 2026
Q2 FY26YoY6M FY26
Revenue$40.9B+26.2%–
Net income$693.0M+27.6%–
Op income$1.4B––
EPS (dil.)$5.731+27.1%$15.55
EPS (basic)$5.78+27.9%$15.64
Op margin3.3%-0.1pp
Net margin1.7%+0.0pp
  1. [1] “Reports 2Q26 earnings per share (EPS) of $5.73 on a GAAP basis, Adjusted EPS of $7.61; reports year to date (YTD) 2026 EPS of $15.55 on a GAAP basis, $17.91 on an Adjusted basis” view source

Guidance & outlook

Management guidance

Q2 2026

fy_current

eps_diluted
No specific guidance provided
eps_diluted
No specific guidance provided
other
93—93
other
10—10
other
25000—100000

Special items & operational metrics

Operational metrics

Q2 2026
CenterWell Primary Care Centers
398
+18.8% YoY
Prior year: 335
centers
CenterWell Primary Care Patients
622.0K
+44.6% YoY
Prior year: 430.3K
patients
Days in Claims Payable
33.1
-9.3% YoY
Prior year: 36.5
days
Q1 2026$39.6B+23.5%$1.2B$9.83Apr 29, 2026
Earnings filing (8-K)10-QFiled Apr 29, 2026, 6:06 AM ET
Earnings call · Apr 29, 2026transcriptView originalprepared remarksQ&A
Q1 FY26YoY
Revenue$39.6B+23.5%
Net income$1.2B-4.7%
Op income$1.8B-12.9%
EPS (dil.)$9.831-4.6%
EPS (basic)$9.85-4.5%
Op margin10.2%+3.9pp
Net margin3.0%-0.9pp
  1. [1] “Reports 1Q26 earnings per share (EPS) of $9.83 on a GAAP basis, Adjusted EPS of $10.31; at the high end of the company's guidance of approximately 110 percent to 115 percent of full year (FY) 2026 Adj” view source
Q4 2025$32.5B+11.3%–$-6.61Feb 11, 2026
Earnings filing (8-K)10-KFiled Feb 11, 2026, 6:40 AM ET
Earnings call · Feb 11, 2026transcriptView originalprepared remarksQ&A
Q4 FY25YoYFY25
Revenue$32.5B+11.3%$129.7B
Net income–––
Op income–––
EPS (dil.)$-6.61––
EPS (basic)–––
Q3 2025$32.6B+11.1%–$1.62Nov 5, 2025
Earnings filing (8-K)10-QFiled Nov 5, 2025, 5:11 AM ET
Earnings call · Nov 5, 2025transcriptView original
Q3 FY25YoY9M FY25
Revenue$32.6B+11.1%$97.1B
Net income–––
Op income–––
EPS (dil.)$1.62-59.3%$16.43
EPS (basic)–––

IR event calendar

This company's IR event calendar has not been harvested yet — an empty result here does NOT mean the company has no IR events.

Filing coverage

61 filings indexed · 82,170 XBRL facts
FilingDatePeriodSectionsTables
8-K2026-07-29–30
10-Q2026-07-29–3145
8-K2026-07-29Q2 2026110
8-K2026-05-19–20
10-Q2026-04-29–3150
8-K2026-04-29Q1 2026120
8-K2026-04-20–10
8-K2026-04-10–30
8-K2026-03-09–40
10-K2026-02-19–5195

Showing the latest 10 of 61 — the full set is in the API.

Related Research

Analysis

UnitedHealth's Medical Cost Crisis Is Worse Than Any Peer

Analysis

Only 28% of Humana's Cash Flow Collapse Has a Clear Cause